OM Stock Overview
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Outset Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.38 |
| 52 Week High | US$24.13 |
| 52 Week Low | US$1.92 |
| Beta | 1.98 |
| 1 Month Change | 8.18% |
| 3 Month Change | -32.00% |
| 1 Year Change | -86.27% |
| 3 Year Change | -95.91% |
| 5 Year Change | n/a |
| Change since IPO | -96.08% |
Recent News & Updates
Recent updates
Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%
Feb 14
Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors
Jun 09Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital
Sep 20Outset Medical awarded VA contract for hemodialysis
Aug 15Outset Medical jumps 24% after 2Q results as FDA clears hemodialysis system
Aug 01Outset Medical: Margins Leave No Tangible Value Flow, Pricing 18% Downside
Jul 06Outset Medical Grows Revenue But Operating Losses Remain High
Dec 29Shareholder Returns
| OM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.8% | 1.6% | 1.0% |
| 1Y | -86.3% | -1.4% | 21.9% |
Return vs Industry: OM underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: OM underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| OM volatility | |
|---|---|
| OM Average Weekly Movement | 13.7% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OM's share price has been volatile over the past 3 months.
Volatility Over Time: OM's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 480 | Leslie Trigg | www.outsetmedical.com |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.
Outset Medical, Inc. Fundamentals Summary
| OM fundamental statistics | |
|---|---|
| Market cap | US$123.05m |
| Earnings (TTM) | -US$172.80m |
| Revenue (TTM) | US$130.38m |
0.9x
P/S Ratio-0.7x
P/E RatioIs OM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OM income statement (TTM) | |
|---|---|
| Revenue | US$130.38m |
| Cost of Revenue | US$101.38m |
| Gross Profit | US$29.00m |
| Other Expenses | US$201.80m |
| Earnings | -US$172.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -3.34 |
| Gross Margin | 22.24% |
| Net Profit Margin | -132.54% |
| Debt/Equity Ratio | 105.9% |
How did OM perform over the long term?
See historical performance and comparison